The New York Times reports that full US approval is fast approaching for Pfizer's coronavirus vaccine, with reference to sources with insider knowledge at the US Food and Drug Administration (FDA).
The vaccine has been approved for emergency use, and more than 165 million US residents are already fully vaccinated.
More from MedWatch
In 2015, Genmab partnered with relatively unknown biotech firm Biontech. Reflecting on how far Genmab has come since, CEO Jan van de Winkel is still confident that partnerships, rather than acquisitions, are the way forward. If it had acquired Biontech at the time, the CEO speculates Genmab may have put a stop to other activities – including the Covid-19 vaccine efforts that went on to save millions of lives. This and fairness are worth remembering as biotech firms are increasingly strapped for cash, van de Winkel reflects.